Literature DB >> 30461258

Investigation of Human Neutrophil Elastase Inhibition by Staphylococcus aureus EapH1: The Key Role Played by Arginine 89.

Timothy J Herdendorf1, Brian V Geisbrecht1.   

Abstract

Staphylococcus aureus secretes a family of potent, noncovalent inhibitory proteins that selectively target the neutrophil serine proteases neutrophil elastase, cathepsin-G, and proteinase-3. A majority of our understanding of these so-called EAP domain proteins has come from structure/function studies on EapH1 and its effects on human neutrophil elastase (hNE). Inspection of the EapH1/hNE cocrystal structure suggested that EapH1 residues R89, E94, and K95 are positioned near the EapH1/hNE interface and might contribute to the potent inhibition of hNE by EapH1. In this study, we used site directed mutagenesis, kinetic evaluation, and surface plasmon resonance to probe the individual contributions of R89, E94, and K95 to EapH1 function. We found that the wild-type EapH1/hNE complex is characterized by a fast association rate (2.0 × 106 M-1 s-1) and a very slow dissociation rate (4.3 × 10-5 s-1), yielding an apparent inhibition constant of 21 pM. The slow dissociation rate of EapH1 from hNE resulted in a time-dependent inhibition pattern. Although conservative mutants E94Q and K95M, as well as the E94Q/K95M double mutant, had on- and off-rates comparable to wild-type EapH1, mutation of R89 to methionine resulted in a 15,000-fold decrease in inhibition (321 nM) and loss of the time-dependent inhibition characteristic. The double mutants R89M/E94Q and R89M/K95M, as well as the triple mutant R89M/E94Q/K95M were similarly perturbed. Mutation of R89 to lysine restored a portion of the inhibition of hNE (27 nM). Given these observations, we conclude that R89 is a primary contributor to EapH1 function vis-à-vis time-dependent inhibition of hNE.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30461258      PMCID: PMC6347974          DOI: 10.1021/acs.biochem.8b01134

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  30 in total

1.  The Staphylococcus aureus extracellular adherence protein (Eap) adopts an elongated but structured conformation in solution.

Authors:  Michal Hammel; Daniel Nemecek; J Andrew Keightley; George J Thomas; Brian V Geisbrecht
Journal:  Protein Sci       Date:  2007-12       Impact factor: 6.725

Review 2.  Granules of the human neutrophilic polymorphonuclear leukocyte.

Authors:  N Borregaard; J B Cowland
Journal:  Blood       Date:  1997-05-15       Impact factor: 22.113

3.  Slow-tight binding inhibition of xylanase by an aspartic protease inhibitor: kinetic parameters and conformational changes that determine the affinity and selectivity of the bifunctional nature of the inhibitor.

Authors:  Chandravanu Dash; Vinod Vathipadiekal; Sudeep P George; Mala Rao
Journal:  J Biol Chem       Date:  2002-02-13       Impact factor: 5.157

4.  Mapping the extended substrate binding site of cathepsin G and human leukocyte elastase. Studies with peptide substrates related to the alpha 1-protease inhibitor reactive site.

Authors:  K Nakajima; J C Powers; B M Ashe; M Zimmerman
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

5.  Proteinase 3. A distinct human polymorphonuclear leukocyte proteinase that produces emphysema in hamsters.

Authors:  R C Kao; N G Wehner; K M Skubitz; B H Gray; J R Hoidal
Journal:  J Clin Invest       Date:  1988-12       Impact factor: 14.808

6.  The neutral proteases of human granulocytes. Isolation and partial characterization of granulocyte elastases.

Authors:  K Ohlsson; I Olsson
Journal:  Eur J Biochem       Date:  1974-03-01

7.  1H, 15N, and 13C resonance assignments of the third domain from the S. aureus innate immune evasion protein Eap.

Authors:  Alvaro I Herrera; Nicoleta T Ploscariu; Brian V Geisbrecht; Om Prakash
Journal:  Biomol NMR Assign       Date:  2018-01-25       Impact factor: 0.746

Review 8.  How human neutrophils kill and degrade microbes: an integrated view.

Authors:  William M Nauseef
Journal:  Immunol Rev       Date:  2007-10       Impact factor: 12.988

9.  Staphylococcus aureus secretes a unique class of neutrophil serine protease inhibitors.

Authors:  Daphne A C Stapels; Kasra X Ramyar; Markus Bischoff; Maren von Köckritz-Blickwede; Fin J Milder; Maartje Ruyken; Janina Eisenbeis; William J McWhorter; Mathias Herrmann; Kok P M van Kessel; Brian V Geisbrecht; Suzan H M Rooijakkers
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-26       Impact factor: 11.205

10.  SWISS-MODEL: homology modelling of protein structures and complexes.

Authors:  Andrew Waterhouse; Martino Bertoni; Stefan Bienert; Gabriel Studer; Gerardo Tauriello; Rafal Gumienny; Florian T Heer; Tjaart A P de Beer; Christine Rempfer; Lorenza Bordoli; Rosalba Lepore; Torsten Schwede
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

View more
  4 in total

1.  Local structural plasticity of the Staphylococcus aureus evasion protein EapH1 enables engagement with multiple neutrophil serine proteases.

Authors:  Timothy J Herdendorf; Daphne A C Stapels; Suzan H M Rooijakkers; Brian V Geisbrecht
Journal:  J Biol Chem       Date:  2020-04-17       Impact factor: 5.157

2.  Staphylococcus aureus Tet38 Efflux Pump Structural Modeling and Roles of Essential Residues in Drug Efflux and Host Cell Internalization.

Authors:  Q C Truong-Bolduc; Y Wang; D C Hooper
Journal:  Infect Immun       Date:  2021-04-16       Impact factor: 3.441

3.  Staphylococcus aureus evasion proteins EapH1 and EapH2: Residue-level investigation of an alternative binding motif for human neutrophil elastase.

Authors:  Timothy J Herdendorf; Brian V Geisbrecht
Journal:  Arch Biochem Biophys       Date:  2019-10-14       Impact factor: 4.013

Review 4.  Staphylococcus aureus and Neutrophil Extracellular Traps: The Master Manipulator Meets Its Match in Immunothrombosis.

Authors:  Severien Meyers; Marilena Crescente; Peter Verhamme; Kimberly Martinod
Journal:  Arterioscler Thromb Vasc Biol       Date:  2022-02-03       Impact factor: 8.311

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.